Gotowe bibliografie tematyczne / Interleukin 10 / Artykuły w czasopismach
Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Interleukin 10.

Artykuły w czasopismach na temat „Interleukin 10”

Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 11 marca 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Interleukin 10”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

&NA;. "Interleukin-10". Drugs in R & D 1, nr 3 (styczeń 1999): 262–64. http://dx.doi.org/10.2165/00126839-199901030-00017.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Asadullah, K., R. Sabat, M. Friedrich, W. Docke, H. Volk i W. Sterry. "Interleukin-10". Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 5, nr 3 (1.08.2006): 223–31. http://dx.doi.org/10.2174/187152306778017700.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Parsons, Polly E. "Interleukin-10". Critical Care Medicine 26, nr 5 (maj 1998): 818–19. http://dx.doi.org/10.1097/00003246-199805000-00007.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Goldman, Michel, Thierry Velu i Marina Pretolani. "Interleukin-10". BioDrugs 7, nr 1 (styczeń 1997): 6–14. http://dx.doi.org/10.2165/00063030-199707010-00002.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Moore, K. W., A. O'Garra, R. W. Malefyt, P. Vieira i T. R. Mosmann. "Interleukin-10". Annual Review of Immunology 11, nr 1 (kwiecień 1993): 165–90. http://dx.doi.org/10.1146/annurev.iy.11.040193.001121.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Umetsu, Dale T., i Rosemarie H. DeKruyff. "Interleukin-10". American Journal of Respiratory Cell and Molecular Biology 21, nr 5 (listopad 1999): 562–63. http://dx.doi.org/10.1165/ajrcmb.21.5.f171.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Zlotnik, Albert, i Kevin W. Moore. "Interleukin 10". Cytokine 3, nr 5 (wrzesień 1991): 366–71. http://dx.doi.org/10.1016/1043-4666(91)90039-g.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Klava, Andrew. "Interleukin-10". Archives of Surgery 132, nr 4 (1.04.1997): 425. http://dx.doi.org/10.1001/archsurg.1997.01430280099016.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

DEWAALMALEFYT, R., M. RONCAROLO, H. SPITS i J. DEVRIES. "Interleukin-10". Current Opinion in Immunology 4, nr 3 (czerwiec 1992): 314–20. http://dx.doi.org/10.1016/0952-7915(92)90082-p.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Reineke, Ulrich, Robert Sabat, Hans-Dieter Volk i Jens Schneider-Mergener. "Mapping of the interleukin-10/interleukin-10 receptor combining site". Protein Science 7, nr 4 (kwiecień 1998): 951–60. http://dx.doi.org/10.1002/pro.5560070412.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
11

Shah, Neil, Jochen Kammermeier, Mamoun Elawad i Erik-Oliver Glocker. "Interleukin-10 and Interleukin-10–Receptor Defects in Inflammatory Bowel Disease". Current Allergy and Asthma Reports 12, nr 5 (14.08.2012): 373–79. http://dx.doi.org/10.1007/s11882-012-0286-z.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

Mittal, Sharad K., Kyung-Jin Cho, Satoshi Ishido i Paul A. Roche. "Interleukin 10 (IL-10)-mediated Immunosuppression". Journal of Biological Chemistry 290, nr 45 (25.09.2015): 27158–67. http://dx.doi.org/10.1074/jbc.m115.682708.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

Holland, Gina, i Albert Zlotnik. "Interleukin-10 and Cancer". Cancer Investigation 11, nr 6 (styczeń 1993): 751–58. http://dx.doi.org/10.3109/07357909309046950.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
14

Kato, Masato. "Interleukin-10 and Surgery". Critical Care Medicine 29, nr 5 (maj 2001): 1093. http://dx.doi.org/10.1097/00003246-200105000-00054.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
15

Cohen, Stacey L., Aideen M. Moore i Wendy E. Ward. "Interleukin-10 Knockout Mouse:". Inflammatory Bowel Diseases 10, nr 5 (wrzesień 2004): 557–63. http://dx.doi.org/10.1097/00054725-200409000-00009.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

Rennick, Donna, Dan Berg i Gina Holland. "Interleukin 10: An overview". Progress in Growth Factor Research 4, nr 3 (styczeń 1992): 207–27. http://dx.doi.org/10.1016/0955-2235(92)90020-i.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
17

Elson, C. O. "Interleukin-10 and counting …". Gastroenterology 100, nr 6 (czerwiec 1991): 1778. http://dx.doi.org/10.1016/0016-5085(91)90687-g.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
18

Sabat, Robert, Gerald Grütz, Katarzyna Warszawska, Stefan Kirsch, Ellen Witte, Kerstin Wolk i Jens Geginat. "Biology of interleukin-10". Cytokine & Growth Factor Reviews 21, nr 5 (październik 2010): 331–44. http://dx.doi.org/10.1016/j.cytogfr.2010.09.002.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
19

Brennan, F. "Interleukin 10 and arthritis". Rheumatology 38, nr 4 (1.04.1999): 293–97. http://dx.doi.org/10.1093/rheumatology/38.4.293.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
20

Montero, J. G. "Interleukin 10 and Sepsis". Archives of Surgery 135, nr 7 (1.07.2000): 875–76. http://dx.doi.org/10.1001/archsurg.135.7.875.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
21

Peng, Hui, Wei Wang, Mo Zhou, Rui Li, Hai-Feng Pan i Dong-Qing Ye. "Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus". Clinical Rheumatology 32, nr 9 (25.05.2013): 1255–66. http://dx.doi.org/10.1007/s10067-013-2294-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
22

Peng, Chih-Wen, Hao-Jen Hsu, Chun-Chun Chang, Cheng-Der Liu, Sheng-Feng Pan i Wei-Han Huang. "Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation". Tzu Chi Medical Journal 32, nr 3 (2020): 245. http://dx.doi.org/10.4103/tcmj.tcmj_237_19.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
23

Wang, P., P. Wu, JC Anthes, MI Siegel, RW Egan i MM Billah. "Interleukin-10 inhibits interleukin-8 production in human neutrophils". Blood 83, nr 9 (1.05.1994): 2678–83. http://dx.doi.org/10.1182/blood.v83.9.2678.2678.

Pełny tekst źródła
Streszczenie:
Abstract In highly purified human polymorphonuclear leukocyte (PMN) preparations containing less than 0.1% contaminating monocytes, significant amounts of interleukin-8 (IL-8) and small amounts of IL-1 alpha, IL-1 beta, and tumor necrosis factor-alpha (TNF-alpha) were produced by lipopolysaccharide (LPS) stimulation. Contrary to published reports, IL- 6 production could not be detected. IL-10 inhibited the production of IL-1 alpha, IL-1 beta, IL-8, and TNF-alpha in LPS-stimulated PMNs, as it did in human blood mononuclear cell (MNC) preparations enriched in monocytes. Subsequent investigation of cytokine synthesis inhibitory effect of IL-10 on PMNs was focused on IL-8. IL-10 inhibited IL-8 synthesis in a dose-dependent manner and, in this regard, it was more potent than IL-4 and transforming growth factor-beta 1 (TGF-B1). In both MNCs and PMNs, degradation of LPS-induced IL-8 mRNA was enhanced by IL-10. Furthermore, as determined by nuclear run-on assays, IL-10 inhibited LPS-induced transcription of IL-8 gene in MNCs. However, in PMNs, run-on assays could not reliably detect IL-8 gene transcription. These results provide the first evidence that the human peripheral neutrophil is a target for inhibition of cytokine synthesis by IL-10, and that IL-10 acts by affecting both gene transcription and mRNA stability.
Style APA, Harvard, Vancouver, ISO itp.
24

Wang, P., P. Wu, JC Anthes, MI Siegel, RW Egan i MM Billah. "Interleukin-10 inhibits interleukin-8 production in human neutrophils". Blood 83, nr 9 (1.05.1994): 2678–83. http://dx.doi.org/10.1182/blood.v83.9.2678.bloodjournal8392678.

Pełny tekst źródła
Streszczenie:
In highly purified human polymorphonuclear leukocyte (PMN) preparations containing less than 0.1% contaminating monocytes, significant amounts of interleukin-8 (IL-8) and small amounts of IL-1 alpha, IL-1 beta, and tumor necrosis factor-alpha (TNF-alpha) were produced by lipopolysaccharide (LPS) stimulation. Contrary to published reports, IL- 6 production could not be detected. IL-10 inhibited the production of IL-1 alpha, IL-1 beta, IL-8, and TNF-alpha in LPS-stimulated PMNs, as it did in human blood mononuclear cell (MNC) preparations enriched in monocytes. Subsequent investigation of cytokine synthesis inhibitory effect of IL-10 on PMNs was focused on IL-8. IL-10 inhibited IL-8 synthesis in a dose-dependent manner and, in this regard, it was more potent than IL-4 and transforming growth factor-beta 1 (TGF-B1). In both MNCs and PMNs, degradation of LPS-induced IL-8 mRNA was enhanced by IL-10. Furthermore, as determined by nuclear run-on assays, IL-10 inhibited LPS-induced transcription of IL-8 gene in MNCs. However, in PMNs, run-on assays could not reliably detect IL-8 gene transcription. These results provide the first evidence that the human peripheral neutrophil is a target for inhibition of cytokine synthesis by IL-10, and that IL-10 acts by affecting both gene transcription and mRNA stability.
Style APA, Harvard, Vancouver, ISO itp.
25

Rentzos, M., C. Nikolaou, E. Andreadou, G. P. Paraskevas, A. Rombos, M. Zoga, A. Tsoutsou, F. Boufidou, E. Kapaki i D. Vassilopoulos. "Circulating interleukin-10 and interleukin-12 in Parkinson’s disease". Acta Neurologica Scandinavica 119, nr 5 (maj 2009): 332–37. http://dx.doi.org/10.1111/j.1600-0404.2008.01103.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
26

Iwasaki, Yasuo, Shigeji Baba i Ken Ikeda. "Interleukin 4 and Interleukin 10 in Creutzfeldt-Jakob Disease". Archives of Neurology 63, nr 6 (1.06.2006): 911. http://dx.doi.org/10.1001/archneur.63.6.911-a.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
27

Ammirati, Enrico, Carlo V. Cannistraci, Nicole A. Cristell, Viviana Vecchio, Alessio G. Palini, Per Tornvall, Anna M. Paganoni i in. "Identification and Predictive Value of Interleukin-6 + Interleukin-10 + and Interleukin-6 − Interleukin-10 + Cytokine Patterns in ST-Elevation Acute Myocardial Infarction". Circulation Research 111, nr 10 (26.10.2012): 1336–48. http://dx.doi.org/10.1161/circresaha.111.262477.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
28

Freer, Giulia. "Interleukin 10 in Antiviral Responses". Current Immunology Reviews 12, nr 1 (30.03.2016): 20–26. http://dx.doi.org/10.2174/1573395512666151216210559.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
29

Benjamin, David, Chanun D. Park i Venkatanarayanan Sharma. "Human B Cell Interleukin 10". Leukemia & Lymphoma 12, nr 3-4 (styczeń 1994): 205–9. http://dx.doi.org/10.3109/10428199409059591.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
30

Cihakova, Daniela. "Interleukin-10 stiffens the heart". Journal of Experimental Medicine 215, nr 2 (18.01.2018): 379–81. http://dx.doi.org/10.1084/jem.20180049.

Pełny tekst źródła
Streszczenie:
Cardiac-resident macrophages are a diverse population of cells that have a critical role in the pathogenesis of heart failure. A new understanding of communication between macrophages and cardiac fibroblasts could lead to novel therapeutic strategies for heart failure with preserved ejection function.
Style APA, Harvard, Vancouver, ISO itp.
31

SCHREIBER, STEFAN. "Interleukin-10 in the intestine". Gut 41, nr 2 (1.08.1997): 274–75. http://dx.doi.org/10.1136/gut.41.2.274.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
32

Garofalo, Roberto, Sadhana Chheda, Fang Mei, Kimberly H. Palkowetz, Helen E. Rudloff, Frank C. Schmalstieg, David K. Rassin i Armond S. Goldman. "Interleukin-10 in Human Milk". Pediatric Research 37, nr 4 (kwiecień 1995): 444–49. http://dx.doi.org/10.1203/00006450-199504000-00010.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
33

Bogdan, C., Y. Vodovotz i C. Nathan. "Macrophage deactivation by interleukin 10." Journal of Experimental Medicine 174, nr 6 (1.12.1991): 1549–55. http://dx.doi.org/10.1084/jem.174.6.1549.

Pełny tekst źródła
Streszczenie:
Recombinant mouse interleukin 10 (IL-10) was exceedingly potent at suppressing the ability of mouse peritoneal macrophages (m phi) to release tumor necrosis factor alpha (TNF-alpha). The IC50 of IL-10 for the suppression of TNF-alpha release induced by 0.5 microgram/ml lipopolysaccharide was 0.04 +/- 0.03 U/ml, with as little as 1 U/ml suppressing TNF-alpha production by a factor of 21.4 +/- 2.5. At 10 U/ml, IL-10 markedly suppressed m phi release of reactive oxygen intermediates (ROI) (IC50 3.7 +/- 1.8 U/ml), but only weakly inhibited m phi release of reactive nitrogen intermediates (RNI). Since TNF-alpha is a T cell growth and differentiation factor, whereas ROI and RNI are known to inhibit lymphocyte function, it is possible that m phi exposed to low concentrations of IL-10 suppress lymphocytes. m phi deactivated by higher concentrations of IL-10 might be permissive for the growth of microbial pathogens and tumor cells, as TNF-alpha, ROI, and RNI are major antimicrobial and tumoricidal products of m phi. IL-10's effects on m phi overlap with but are distinct from the effects of the two previously described cytokines that suppress the function of mouse m phi, transforming growth factor beta and macrophage deactivation factor. Based on results with neutralizing antibodies, all three m phi suppressor factors appear to act independently.
Style APA, Harvard, Vancouver, ISO itp.
34

Marchant, A., M. Goldman, J. Devière, B. Byl, J. L. Vincent i D. De Groote. "Interleukin-10 production during septicaemia". Lancet 343, nr 8899 (marzec 1994): 707–8. http://dx.doi.org/10.1016/s0140-6736(94)91584-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
35

Moore, Kevin W., Rene de Waal Malefyt, Robert L. Coffman i Anne O'Garra. "INTERLEUKIN-10AND THEINTERLEUKIN-10 RECEPTOR". Annual Review of Immunology 19, nr 1 (kwiecień 2001): 683–765. http://dx.doi.org/10.1146/annurev.immunol.19.1.683.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
36

Howard, Maureen, Anne O'Garra, Hiroshi Ishida, René de Waal Malefyt i Jan De Vries. "Biological properties of interleukin 10". Journal of Clinical Immunology 12, nr 4 (lipiec 1992): 239–47. http://dx.doi.org/10.1007/bf00918147.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
37

Howard, Maureen, i Anne O'Garra. "Biological properties of interleukin 10". Immunology Today 13, nr 6 (styczeń 1992): 198–200. http://dx.doi.org/10.1016/0167-5699(92)90153-x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
38

Asadullah, Khusru, Wolf-Dietrich Döcke, Robert Sabat, Merle Ebeling, Hans-Dieter Volk i Wolfram Sterry. "Interleukin-10 in der Dermatologie". Der Hautarzt 50, nr 1 (22.01.1999): 12–19. http://dx.doi.org/10.1007/s001050050858.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
39

Wande, I. Nyoman, Endang Retnowati i Juli Soemarsono. "KADAR INTERLEUKIN 10 (IL-10) MALARIA DAN ANEMIA". INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 18, nr 1 (14.10.2016): 4. http://dx.doi.org/10.24293/ijcpml.v18i1.767.

Pełny tekst źródła
Streszczenie:
Anaemia is an important complication of malaria, and its pathogenesis is not well understood. High level of the Th2 cytokine (such as IL-10), which counteract the Th1 cytokine, might prevent the development of severe malarial anaemia. The purpose of this study was to know the comparation between the plasma level of IL-10 in malaria patients with anaemia and without anaemia. The plasma level of IL-10 was examined in 16 malaria patients with anaemia and 16 malaria caused by P. falciparum patients without anaemia samplestaken from patients at the primary health centres in West Lombok and Centre Lombok during March until July 2008. The samples were measured using ELISA. The concentration of haemoglobin (Hb) was measured using hematological analyzer. The anaemia concentration of Hb is <11 g/dL. The results were analyzed using two (2) sample t test with SPSS ver.13.The plasma level of IL-10 in malaria patients caused by P. falciparum with anaemia was 8.81(3.04) [mean(SD)] pg/mL where as the plasma level of IL-10 in malaria patients without anaemia was 47.99(25.26) pg/mL. The mean of IL-10 level in malaria falciparum patients with anaemia was significantly lower than that of malaria patients caused by P. falciparum without anaemia (p=0.000).
Style APA, Harvard, Vancouver, ISO itp.
40

Furukawa, Yutaka, Gerold Becker, Jennifer L. Stinn, Koichi Shimizu, Peter Libby i Richard N. Mitchell. "Interleukin-10 (IL-10) Augments Allograft Arterial Disease". American Journal of Pathology 155, nr 6 (grudzień 1999): 1929–39. http://dx.doi.org/10.1016/s0002-9440(10)65512-5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
41

Salwen, S. A., T. Sato, K. Masuoka, G. Inoue, M. J. Mastrangelo i D. Berd. "INTERLEUKIN-10 (IL-10) PRODUCTION BY MELANOMA CELLS". Journal of Immunotherapy 18, nr 2 (sierpień 1995): 129. http://dx.doi.org/10.1097/00002371-199508000-00014.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
42

BENDTZEN, KLAUS, MORTEN B. HANSEN, MARCUS DIAMANT, CHRISTIAN ROSS i MORTEN SVENSON. "Naturally Occurring Autoantibodies to Interleukin-1α, Interleukin-6, Interleukin-10, and Interferon-α". Journal of Interferon Research 14, nr 4 (sierpień 1994): 157–58. http://dx.doi.org/10.1089/jir.1994.14.157.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
43

Diller, R., D. Palmes, K. H. Dietl, N. Senninger, G. Winde i H. U. Spiegel. "Interleukin-6, interleukin-8, and interleukin-10 in kidney transplantation: improved risk strategy?" Transplantation Proceedings 35, nr 4 (czerwiec 2003): 1333–37. http://dx.doi.org/10.1016/s0041-1345(03)00529-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
44

Tilg, Herbert, Michael B. Atkins, Charles A. Dinarello i James W. Mier. "Induction of circulating interleukin 10 by interleukin 1 and interleukin 2, but not interleukin 6 immunotherapy". Cytokine 7, nr 7 (październik 1995): 734–39. http://dx.doi.org/10.1006/cyto.1995.0087.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
45

MIOSSEC, PIERRE, i Pierre Miossec. "Interleukin-4 and Interleukin-10 as Antagonists of Interferon-γ". Journal of Interferon Research 14, nr 5 (październik 1994): 285. http://dx.doi.org/10.1089/jir.1994.14.285.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
46

Glynn, P., R. Coakley, I. Kilgallen, N. Murphy i S. O'Neill. "Circulating interleukin 6 and interleukin 10 in community acquired pneumonia". Thorax 54, nr 1 (1.01.1999): 51–55. http://dx.doi.org/10.1136/thx.54.1.51.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
47

Kovarik, Johannes J., Elisabeth Kernbauer, Markus A. Hölzl, Johannes Hofer, Guido A. Gualdoni, Klaus G. Schmetterer, Fitore Miftari i in. "Fasting metabolism modulates the interleukin-12/interleukin-10 cytokine axis". PLOS ONE 12, nr 7 (24.07.2017): e0180900. http://dx.doi.org/10.1371/journal.pone.0180900.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
48

Wolk, K., E. Witte, U. Reineke, K. Witte, M. Friedrich, W. Sterry, K. Asadullah, H.-D. Volk i R. Sabat. "Is there an interaction between interleukin-10 and interleukin-22?" Genes & Immunity 6, nr 1 (4.11.2004): 8–18. http://dx.doi.org/10.1038/sj.gene.6364144.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
49

Denison, F. C. "Seminal plasma components stimulate interleukin-8 and interleukin-10 release". Molecular Human Reproduction 5, nr 3 (1.03.1999): 220–26. http://dx.doi.org/10.1093/molehr/5.3.220.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
50

El-Shabrawi, Y. "Interleukin-12 und Interleukin-10 in intraokulären Flüssigkeiten von Uveitispatienten". Spektrum der Augenheilkunde 13, nr 1 (luty 1999): 1–5. http://dx.doi.org/10.1007/bf03162708.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany bibliografiami na temat „Interleukin 10” dla innych typów źródeł:
Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii